Thomas H. Openshaw

1.3k total citations
12 papers, 192 citations indexed

About

Thomas H. Openshaw is a scholar working on Cancer Research, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas H. Openshaw has authored 12 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas H. Openshaw's work include Breast Cancer Treatment Studies (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Clinical practice guidelines implementation (2 papers). Thomas H. Openshaw is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Clinical practice guidelines implementation (2 papers). Thomas H. Openshaw collaborates with scholars based in United States, Israel and Canada. Thomas H. Openshaw's co-authors include Mark R. Somerfield, Diana T. Chingos, Carey K. Anders, Kimberly H. Allison, Vandana G. Abramson, N. Lynn Henry, Ian E. Krop, Arti Hurria, Eric P. Winer and Patricia A. Spears and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Thomas H. Openshaw

11 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas H. Openshaw United States	7	111	98	37	34	26	12	192
Marla Lipsyc-Sharf United States	7	108 1.0×	122 1.2×	60 1.6×	55 1.6×	18 0.7×	24	225
Krystyna Reczko United Kingdom	6	55 0.5×	76 0.8×	40 1.1×	35 1.0×	18 0.7×	10	188
James Pavelka United States	9	67 0.6×	165 1.7×	28 0.8×	33 1.0×	29 1.1×	14	500
Pablo Borrega Spain	8	93 0.8×	93 0.9×	116 3.1×	24 0.7×	10 0.4×	28	243
Silvia Pecchio Italy	8	105 0.9×	143 1.5×	43 1.2×	72 2.1×	15 0.6×	13	306
Felicia Roncolato Australia	8	41 0.4×	133 1.4×	55 1.5×	20 0.6×	12 0.5×	31	247
Kathryn Edmiston United States	9	61 0.5×	130 1.3×	32 0.9×	27 0.8×	25 1.0×	14	280
Jackie Charman United Kingdom	7	88 0.8×	154 1.6×	112 3.0×	50 1.5×	14 0.5×	16	287
Heather Beckwith United States	11	151 1.4×	180 1.8×	58 1.6×	68 2.0×	11 0.4×	22	365
Bo Grønlund Denmark	11	31 0.3×	118 1.2×	42 1.1×	36 1.1×	20 0.8×	25	394

Countries citing papers authored by Thomas H. Openshaw

Since Specialization

Citations

This map shows the geographic impact of Thomas H. Openshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Openshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Openshaw more than expected).

Fields of papers citing papers by Thomas H. Openshaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Openshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Openshaw. The network helps show where Thomas H. Openshaw may publish in the future.

Co-authorship network of co-authors of Thomas H. Openshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Openshaw. A scholar is included among the top collaborators of Thomas H. Openshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Openshaw. Thomas H. Openshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Weiss, Anna, Qingchun Jin, Nabihah Tayob, et al.. (2025). Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial. Annals of Surgical Oncology. 33(3). 2275–2283.

Chen, Wendy Y., Karla V. Ballman, Ann H. Partridge, et al.. (2024). Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer. JAMA. 331(20). 1714–1714. 15 indexed citations

Chen, Wendy Y., Karla V. Ballman, Eric P. Winer, et al.. (2022). A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial. Journal of Clinical Oncology. 40(36_suppl). 360922–360922. 10 indexed citations

Seah, Davinia, José Pablo Leone, Thomas H. Openshaw, et al.. (2020). Perceptions of patients with early stage breast cancer toward research biopsies. Cancer. 127(8). 1208–1219. 3 indexed citations

Metzger, Otto, Anita Giobbie‐Hurder, Nancy U. Lin, et al.. (2020). A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer. Breast Cancer Research and Treatment. 185(1). 135–144. 6 indexed citations

Chen, Wendy Y., Eric P. Winer, Karla V. Ballman, et al.. (2020). ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer.. Journal of Clinical Oncology. 38(15_suppl). TPS600–TPS600. 2 indexed citations

Liu, Minetta C., David W. Hillman, Alan P. Lyss, et al.. (2020). Randomized phase III trial of eribulin (E) versus standard weekly paclitaxel (P) as first- or second-line therapy for locally recurrent or metastatic breast cancer (MBC).. Journal of Clinical Oncology. 38(15_suppl). 1016–1016. 5 indexed citations

Henry, N. Lynn, Mark R. Somerfield, Vandana G. Abramson, et al.. (2019). Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline. Journal of Clinical Oncology. 37(22). 1965–1977. 42 indexed citations

Ashikaga, T., K Wilson, Claire F. Verschraegen, et al.. (2016). Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim. Supportive Care in Cancer. 24(7). 3085–3093. 23 indexed citations

10.

Henry, N. Lynn, Mark R. Somerfield, Vandana G. Abramson, et al.. (2016). Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations. Journal of Clinical Oncology. 34(19). 2303–2311. 61 indexed citations

11.

Seah, Davinia, Julie Najita, Thomas H. Openshaw, et al.. (2013). Attitudes of patients with metastatic breast cancer toward research biopsies. Annals of Oncology. 24(7). 1853–1859. 24 indexed citations

12.

Hertler, Andrew, et al.. (2012). Development of a collaborative improvement network by a state affiliate of the American Society of Clinical Oncology.. Journal of Clinical Oncology. 30(34_suppl). 79–79. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact